Why is edarbyclor so expensive?

When it comes to pharmaceuticals, we all know they can cost an arm and a leg. We’ve heard about $1,000 EpiPens and $2,000-per-pill cancer treatments. But what about Edarbyclor? This blood pressure medication has been raising eyebrows with its high price tag – so what gives? Let’s break down exactly why this drug is causing sticker shock at the pharmacy.

What is Edarbyclor?

First things first: let’s establish what we’re dealing with here. Edarbyclor (azilsartan medoxomil/chlorthalidone) is a combination of two drugs used to treat hypertension (high blood pressure). It works by relaxing blood vessels and increasing urine output to lower your blood pressure.

The Cost of Development

One factor that contributes to the high cost of many prescription medications is the astronomical amount invested in research and development before they hit the market. From coming up with potential compounds to testing them in clinical trials, developing a new drug takes years and millions of dollars.

With that said, Edarbyclor was not necessarily more expensive than other promising candidate drugs when it was being developed. However, after passing several phases of clinical trials successfully enough for its manufacturer Azur Pharma Inc., which later merged into Allergen Plc., approved submitting New Drug Application (NDA) form for approval by FDA on July 2010,the costs began add up.

Accordingly,, By time taken from submission till approval-to-market period under studying ,if you include indirect expenses like salaries paid to employees or contractor fees involved during R&D activities can easily lead total expense over hundreds million US dollars per single novel drug candidates( whereas some studies report that overall expenditure might exceed one billion USD excluding opportunity costs).

Of course, these figures are staggering, and they inevitably factor into the final cost of medications like Edarbyclor.

The Cost of Marketing

Another reason why pharmaceuticals are so expensive is marketing. Once a drug has been approved by the FDA, its manufacturer needs to get it out there and convince doctors to prescribe it. That means advertising campaigns, sales reps, free samples – you name it.

Again in case of Azur’s R&D expenses for developing Edarbyclor had already surpassed millions USD, the company might want a good return on their investment through successful market uptake since patent protection only lasts 20 years from initial date of filing regardless if some portion of that had spent during development period or as part activities related with profit making driving demand-marketing strategies. While companies may disagree with approaches taken to pricing policies typically revolving around maximizing profits considering relationships between benefits,costs-investments & risks encountered induced by future uncertainties after approval(i.e litigation or political pressure) when immediate gains generated overrides any long-term consequences affecting company reputation or external images perceived various audiences.

In short: while lucrative, marketing costs money – and lots of it. And these costs ultimately trickle down to consumers in the form of higher prices at the pharmacy counter.

Patents and Exclusivity

As we mentioned earlier, patents are an essential component in brining drugs into this world- They basically give innovators exclusivity over their products for several years until other competitors can make generic versions

Typically ,patent life extensions can be obtained upto additional five-plus years taking advantage regulatory programs (like pediatric exclusivity) known as Hatch-Waxman Act bestowing exclusive manufacturing rights based on certain requirements . From industry perspective where competition inevitable challenge faced constantly influencing further innovation limits throughout product lifespan whose value coverage would diminish more quickly without extending protections granted post-commercialization stage sustains some sort certainty about foreseeable among alternative commodities introduced markets later point time.

However, these limited monopolies can cause market inefficiencies that lead to high prices for consumers. In Edarbyclor’s case, the drug’s patents don’t expire until 2023 and 2026, respectively – which means other companies can’t make generic versions yet.

Supply Chain Costs

Even after a medication has been developed, marketed and patented , there are still numerous costs associated with getting it from the manufacturer into the hands of patients.

From manufacturing the drugsto transporting them, securing their quality throughout supply chain against counterfeiting or contamination risks(due reasons like change in temperature , moisture levels) while storing-and handling them safely(Cold-chains usually), logistics expenses like insurance policies acquired covering liability concerns about production failures during transit specific geographic territories . The list goes on- but suffice to say that each step along this journey adds a little extra cost to every prescription filled.

Other Factors

Of course, these aren’t the only factors driving up Edarbyclor’s price point.From bargaining power exerted by suppliers contracted providing raw materials(giving rise negotiation carried out based upon demand driven actions especially when such materials scare resources needed producing unique substance) aspects influenced by hospital reimbursement schemes affecting availability source treatments offered within setting financial institutions,(i.e copays)driven-largely concerned-markets demographic conditions characterized population trends correlated chronic illnesses &insurance coverage provisions adopted different countries influenced foreign pricing arrangements reports indicating some may take advantage lower prices available aboard expatriating fears impacting runaway health expenditure(cost-shifting strategies used mitigating pain-side burdens employees contribute program funds ). Plus many more nuanced variables all come together adding-up creating massive monster what referring at end( $$$$).

Edarbyclor is an effective treatment for hypertension – But its price tag begs questions: Why so expensive? It turns-out developing novel drugs is hard-hitting endeavor whose costs must be recuperated adding to storage, transportation logistics,and other supply chain expenses needed deploying at large-scale production capacities . Plus a lengthy patent life coupled with marketing campaigns whose strategies revolve around driving demand add up to create one hefty tab once it appears on consumers’ invoices. So next time you’re faced with an exorbitant pharmacy bill, remember: there are often many factors that go into making a drug expensive beyond the sticker price alone.

Random Posts